Evidence mapPaperPMID 36913129Full record

ReviewGeroScience2023

Ovarian aging in humans: potential strategies for extending reproductive lifespan.

Marcelo Borges Cavalcante, Olga Goiana Martins Sampaio, Fernanda Eunice Araújo Câmara, Augusto Schneider, Bianca Machado de Ávila, Juliane Prosczek, Michal M Masternak, Adriana Rolim Campos

Open access · greenAbstract readReview
In one paragraph

Review in GeroScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
23.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Marcelo Borges CavalcantePostgraduate Program in Medical Sciences, University of Fortaleza (UNIFOR), Fortaleza, CE, 60.811-905, Brazil. marcelocavalcante.med@gmail.com.ORCID 0000-0001-9943-9731
Olga Goiana Martins SampaioPostgraduate Program in Medical Sciences, University of Fortaleza (UNIFOR), Fortaleza, CE, 60.811-905, Brazil.
Fernanda Eunice Araújo CâmaraPostgraduate Program in Medical Sciences, University of Fortaleza (UNIFOR), Fortaleza, CE, 60.811-905, Brazil.
Augusto SchneiderNutrition College, Federal University of Pelotas (UFPel), Pelotas, RS, 96010-610, Brazil.
Bianca Machado de ÁvilaNutrition College, Federal University of Pelotas (UFPel), Pelotas, RS, 96010-610, Brazil.
Juliane ProsczekNutrition College, Federal University of Pelotas (UFPel), Pelotas, RS, 96010-610, Brazil.
Michal M MasternakBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando FL, USA.
Adriana Rolim CamposDepartment of Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland.
Universidade de Fortaleza · BRUniversidade Federal de Pelotas · BRPoznan University of Medical Sciences · PLUniversity of Central Florida · US

Funding

NIA NIH HHS R56 AG074499
6 · The paper itself

Abstract

Ovarian reserve is a term used to estimate the total number of immature follicles present in the ovaries. Between birth and menopause, there is a progressive decrease in the number of ovarian follicles. Ovarian aging is a continuous physiological phenomenon, with menopause being the clinical mark of the end of ovarian function. Genetics, measured as family history for age at the onset of menopause, is the main determinant. However, physical activity, diet, and lifestyle are important factors that can influence the age of menopause. The low estrogen levels after natural or premature menopause increased the risk for several diseases, resulting in increased mortality risk. Besides that, the decreasing ovarian reserve is associated to reduced fertility. In women with infertility undergoing in vitro fertilization, reduced markers of ovarian reserve, including antral follicular count and anti-Mullerian hormone, are the main indicators of reduced chances of becoming pregnant. Therefore, it becomes clear that the ovarian reserve has a central role in women's life, affecting fertility early in life and overall health later in life. Based on this, the ideal strategy for delaying ovarian aging should have the following characteristics: (1) be initiated in the presence of good ovarian reserve; (2) maintained for a long period; (3) have an action on the dynamics of primordial follicles, controlling the rate of activation and atresia; and (4) safe use in pre-conception, pregnancy, and lactation. In this review, we therefore discuss some of these strategies and its feasibility for preventing a decline in the ovarian reserve.

Indexed as

LongevityOvaryAgingFemaleFertilityHumansPregnancyReproductionAgingFemalesFertilityMenopauseOvarian reserve

Identifiers

PMID36913129
PMCPMC10651588
OpenAlexW4324021314

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.